Decitabine in patients with myelodysplastic syndromes: A multi-center, open-label, dose comparison trial.

Hui LiuHao JiangHongyan TongRuixiang XiaLinhua YangHongguo ZhaoJian OuyangHai BaiHui SunLi HouMing JiangYun ZengZhuogang LiuAibin LiangYinghua XieKang YuZhimin ZhaiLi LiuJin-Song Jia Wenhui LeiZonghong Shao

Published in: Cancer medicine (2023)

/day decitabine regimens have similar efficacy and safety in patients with intermediate or high risk MDS.

Keyphrases

open label
acute myeloid leukemia
phase iii
phase ii
study protocol
clinical trial
phase ii study
randomized controlled trial
double blind
radiation therapy
clinical evaluation
placebo controlled